We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Actinomycin V Induces Apoptosis Associated with Mitochondrial and PI3K/AKT Pathways in Human CRC Cells.
- Authors
Jiang, Shiqing; Zhang, E; Ruan, Hang; Ma, Jiahui; Zhao, Xingming; Zhu, Yaoyao; Xie, Xiaoyu; Han, Ningning; Li, Jianjiang; Zhang, Hao; Xie, Weidong; Li, Xia
- Abstract
Actinomycin (Act) V, an analogue of Act D, presented stronger antitumor activity and less hepatorenal toxicity than Act D in our previous studies, which is worthy of further investigation. We hereby report that Act V induces apoptosis via mitochondrial and PI3K/AKT pathways in colorectal cancer (CRC) cells. Act V-induced apoptosis was characterized by mitochondrial dysfunction, with loss of mitochondria membrane potential (MMP) and cytochrome c release, which then activated cleaved caspase-9, cleaved caspase-3, and cleaved PARP, revealing that it was related to the mitochondrial pathway, and the apoptotic trendency can be reversed by caspase inhibitor Z-VAD-FMK. Furthermore, we proved that Act V significantly inhibited PI3K/AKT signalling in HCT-116 cells using cell experiments in vitro, and it also presented a potential targeted PI3Kα inhibition using computer docking models. Further elucidation revealed that it exhibited a 28-fold greater potency than the PI3K inhibitor LY294002 on PI3K inhibition efficacy. Taken together, Act V, as a superior potential replacement of Act D, is a potential candidate for inhibiting the PI3K/AKT pathway and is worthy of more pre-clinical studies in the therapy of CRC.
- Subjects
PI3K/AKT pathway; ACTINOMYCIN; MITOCHONDRIA; COLORECTAL cancer; APOPTOSIS; CELL death; CELL communication
- Publication
Marine Drugs, 2021, Vol 19, Issue 11, p599
- ISSN
1660-3397
- Publication type
Article
- DOI
10.3390/md19110599